NCT04910334

Brief Summary

This study is a prospective observational cohort study of 6 and 12 months long-term outcome of Danish speaking patients with COVID-19.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
203

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 2, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

June 2, 2021

Status Verified

June 1, 2021

Enrollment Period

8 months

First QC Date

February 4, 2021

Last Update Submit

June 1, 2021

Conditions

Keywords

covid-19danish iculong-term follow-up

Outcome Measures

Primary Outcomes (2)

  • The cognitive status at 6 and 12 months after ICU admission using the validated instrument MiniMoCA

    The cognitive status at 6 and 12 months after ICU admission using the validated instrument MiniMoCA. Score 0-15, score above 11 indicate normal cognitive function. Two time points to see if there is a change in the cognitive status over time.

    at 6 and 12 months after ICU admission

  • The functional status at 6 and 12 months after ICU admission using the validated instrument CFS

    The functional status at 6 and 12 months after ICU admission using the validated instrument CFS (score 1-9) higher levels indicate more frailty. Two time points to see if there is a change in the frailty status over time.

    at 6 and 12 months after ICU admission

Secondary Outcomes (7)

  • The association between ventilator days and CFS 6 and 12 months after ICU admission

    at 6 and 12 months after ICU admission

  • The association between ventilator days and MiniMoCA 6 and 12 months after ICU admission

    at 6 and 12 months after ICU admission

  • Mortality 6 and 12 months after ICU admission

    at 6 and 12 months after ICU admission

  • EQ-5D-5L score 6 and 12 months after ICU admission

    at 6 and 12 months after ICU admission

  • Barthel ADL score 6 and 12 months after ICU admission

    at 6 and 12 months after ICU admission

  • +2 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population is all Danish speaking COVID-19 patients, admitted and treated at one of the 29 Danish ICUs, and enrolled in the 'Danish ICU COVID-19 database' from March 10th and forward. Patients are 18 of age and above with a positive polymerase chain reaction (PCR) test for SARS-CoV-2 either prior to or during ICU admission

You may qualify if:

  • \> 18 years
  • enrolled in the 'Danish ICU COVID-19 database'

You may not qualify if:

  • non danish speaking patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anaesthesiology

Køge, 4600, Denmark

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Lone Poulsen, MD

    Department of Anaesthesiology and Intensive Care

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2021

First Posted

June 2, 2021

Study Start

October 1, 2020

Primary Completion

June 1, 2021

Study Completion

September 1, 2021

Last Updated

June 2, 2021

Record last verified: 2021-06

Locations